WO2002055706A2 - Proteines apparentees a la proteine asip - Google Patents

Proteines apparentees a la proteine asip Download PDF

Info

Publication number
WO2002055706A2
WO2002055706A2 PCT/US2002/000647 US0200647W WO02055706A2 WO 2002055706 A2 WO2002055706 A2 WO 2002055706A2 US 0200647 W US0200647 W US 0200647W WO 02055706 A2 WO02055706 A2 WO 02055706A2
Authority
WO
WIPO (PCT)
Prior art keywords
protein
seq
cdna
antibody
molecules
Prior art date
Application number
PCT/US2002/000647
Other languages
English (en)
Other versions
WO2002055706A3 (fr
Inventor
Roopa Reddy
Y Tom Tang
Mariah R Baughn
Randi Krasnow
Original Assignee
Incyte Genomics Inc
Roopa Reddy
Y Tom Tang
Mariah R Baughn
Randi Krasnow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Roopa Reddy, Y Tom Tang, Mariah R Baughn, Randi Krasnow filed Critical Incyte Genomics Inc
Priority to CA002434042A priority Critical patent/CA2434042A1/fr
Priority to JP2002556752A priority patent/JP2005503107A/ja
Priority to EP02713385A priority patent/EP1430129A2/fr
Publication of WO2002055706A2 publication Critical patent/WO2002055706A2/fr
Publication of WO2002055706A3 publication Critical patent/WO2002055706A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des ADNc qui codent des protéines apparentées à la protéine ASIP. Elle concerne aussi l'utilisation des ADNc, de fragments, de compléments et de variantes de ces derniers et des protéines codées, des parties de ces dernières et des anticorps pour le diagnostic et le traitement du cancer, en particulier, du carcinome transitionnel de la vessie. L'invention traite aussi de vecteurs d'expression et de cellules hôtes pour la production de la protéine et d'un système de modèle transgénique.
PCT/US2002/000647 2001-01-09 2002-01-08 Proteines apparentees a la proteine asip WO2002055706A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002434042A CA2434042A1 (fr) 2001-01-09 2002-01-08 Proteines apparentees a la proteine asip
JP2002556752A JP2005503107A (ja) 2001-01-09 2002-01-08 Ａｓｉｐ関連タンパク質
EP02713385A EP1430129A2 (fr) 2001-01-09 2002-01-08 Proteines apparentees a la proteine asip

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/757,781 2001-01-09
US09/757,781 US20020137166A1 (en) 2001-01-09 2001-01-09 ASIP-related proteins

Publications (2)

Publication Number Publication Date
WO2002055706A2 true WO2002055706A2 (fr) 2002-07-18
WO2002055706A3 WO2002055706A3 (fr) 2004-04-15

Family

ID=25049194

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/000647 WO2002055706A2 (fr) 2001-01-09 2002-01-08 Proteines apparentees a la proteine asip

Country Status (5)

Country Link
US (1) US20020137166A1 (fr)
EP (1) EP1430129A2 (fr)
JP (1) JP2005503107A (fr)
CA (1) CA2434042A1 (fr)
WO (1) WO2002055706A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093911A1 (fr) * 2003-04-21 2004-11-04 Yoshiyuki Kakehi Composition pharmaceutique pour le traitement de maladies prostatiques

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093911A1 (fr) * 2003-04-21 2004-11-04 Yoshiyuki Kakehi Composition pharmaceutique pour le traitement de maladies prostatiques

Also Published As

Publication number Publication date
EP1430129A2 (fr) 2004-06-23
WO2002055706A3 (fr) 2004-04-15
JP2005503107A (ja) 2005-02-03
CA2434042A1 (fr) 2002-07-18
US20020137166A1 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
US20020187472A1 (en) Steap-related protein
US20030082533A1 (en) Intelectin
US20140155288A1 (en) Methods for diagnosing cancer
US6566066B1 (en) Aquaporin-8 variant
US6590089B1 (en) RVP-1 variant differentially expressed in Crohn's disease
US6444430B1 (en) Ndr2-related proteins
EP1343891A2 (fr) Marqueur du cancer du colon
US20030211515A1 (en) Novel compounds
US20030166300A1 (en) Growth-related inflammatory and immune response protein
US6783955B2 (en) Polynucleotides encoding human presenilin variant
US6632617B1 (en) Tumor-associated antigen
EP1430129A2 (fr) Proteines apparentees a la proteine asip
US20020025555A1 (en) GPCR diagnostic for brain cancer
US20030166041A1 (en) TIMM8b-related protein
US20020055108A1 (en) Human Sec6 vesicle transport protein
US20030138835A1 (en) Tumor suppressors
WO2002024742A2 (fr) Proteine de cassette de liaison a l'atp
US20020137038A1 (en) Intestinal proteins
US20030068619A1 (en) TNF receptor 2 related protein variant
EP1311665A2 (fr) Proteine specifique au rein
WO2002072861A1 (fr) Antigene de surface cellulaire cd53
WO2002046420A2 (fr) Proteine liee a la nebuline

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002556752

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2434042

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002713385

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002713385

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002713385

Country of ref document: EP